Novavax Inc (NVAX)
9.35
-0.26
(-2.71%)
USD |
NASDAQ |
Nov 01, 16:00
9.42
+0.07
(+0.75%)
After-Hours: 20:00
Novavax Gross Profit Margin (Quarterly): 88.87% for June 30, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 88.87% |
| March 31, 2024 | 36.91% |
| December 31, 2023 | 38.84% |
| September 30, 2023 | -348.4% |
| June 30, 2023 | 86.86% |
| March 31, 2023 | |
| December 31, 2022 | 36.85% |
| September 30, 2022 | 30.83% |
| June 30, 2022 | -45.80% |
| March 31, 2022 | 97.49% |
| December 31, 2021 | |
| September 30, 2021 | |
| June 30, 2021 | |
| March 31, 2021 | |
| December 31, 2020 | |
| September 30, 2020 | |
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 | |
| September 30, 2019 | |
| June 30, 2019 | |
| March 31, 2019 | |
| December 31, 2018 | |
| September 30, 2018 | |
| June 30, 2018 |
| Date | Value |
|---|---|
| March 31, 2018 | |
| December 31, 2017 | |
| September 30, 2017 | |
| June 30, 2017 | |
| March 31, 2017 | |
| December 31, 2016 | |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | |
| September 30, 2015 | |
| June 30, 2015 | |
| March 31, 2015 | |
| December 31, 2014 | |
| September 30, 2014 | 50.97% |
| June 30, 2014 | 38.22% |
| March 31, 2014 | 59.51% |
| December 31, 2013 | |
| September 30, 2013 | 52.60% |
| June 30, 2013 | 53.78% |
| March 31, 2013 | 55.34% |
| December 31, 2012 | 57.25% |
| September 30, 2012 | 33.43% |
| June 30, 2012 | 27.95% |
| March 31, 2012 | 18.44% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
-348.4%
Minimum
Sep 2023
97.49%
Maximum
Mar 2022
2.50%
Average
36.91%
Median
Mar 2024
Gross Profit Margin (Quarterly) Benchmarks
| Pfizer Inc | 70.27% |
| Moderna Inc | 47.96% |
| BioCryst Pharmaceuticals Inc | 98.41% |
| Eli Lilly and Co | 81.02% |
| AIM ImmunoTech Inc | 84.00% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Assets | -17.71% |
| Profit Margin (Quarterly) | 39.08% |
| Operating Margin (Quarterly) | 38.75% |
| Return on Net Operating Assets | -36.48% |